INNV vs. AMLX
INNV (InnovAge Holding Corp.) and AMLX (Amylyx Pharmaceuticals, Inc.) are both stocks. Both are in the Healthcare sector — INNV in Medical Care Facilities, AMLX in Biotechnology. Over the past 3 years, INNV returned 18.02%/yr vs -4.58%/yr for AMLX. Their 0.18 correlation means their historical movements had little consistent relationship.
Performance
INNV vs. AMLX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INNV achieves a 118.88% return, which is significantly higher than AMLX's 68.13% return.
INNV
- 1D
- -2.07%
- 1M
- -5.25%
- 6M
- 104.68%
- YTD
- 118.88%
- 1Y
- 262.94%
- 3Y*
- 18.02%
- 5Y*
- -7.59%
- 10Y*
- —
- ALL TIME*
- -12.92%
AMLX
- 1D
- -2.12%
- 1M
- 11.17%
- 6M
- 42.13%
- YTD
- 68.13%
- 1Y
- 163.25%
- 3Y*
- -4.58%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -0.73%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $41.59M | $31.68M | $25.94M | |
| $2.95M | $3.34M | $3.45M |
INNV vs. AMLX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
INNV InnovAge Holding Corp. | 118.88% | 32.06% | -34.50% | -16.43% | 53.75% |
AMLX Amylyx Pharmaceuticals, Inc. | 68.13% | 219.58% | -74.32% | -60.16% | 75.95% |
Correlation
The correlation between INNV and AMLX is 0.20, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.20 |
Correlation (3Y) Balances recent behavior with more history. | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jan 7, 2022 | 0.18 |
Fundamentals
INNV:
$1.54B
AMLX:
$2.26B
INNV:
-$0.16
AMLX:
-$1.51
INNV:
6.62
AMLX:
8.22
INNV:
$945.90M
AMLX:
$0.00
INNV:
$140.05M
AMLX:
-$20.10M
INNV:
$5.26M
AMLX:
-$150.30M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INNV vs. AMLX — Risk / Return Rank
INNV
AMLX
INNV vs. AMLX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for InnovAge Holding Corp. (INNV) and Amylyx Pharmaceuticals, Inc. (AMLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| INNV | AMLX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.44 | ||
| Sortino ratioReturn per unit of downside risk | +0.38 | ||
| Omega ratioGain probability vs. loss probability | 1.42 | 1.35 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 7.34 | 5.03 | +2.32 |
| Martin ratioReturn relative to average drawdown | 15.83 | 10.76 | +5.07 |
Loading charts...
Drawdowns
INNV vs. AMLX - Drawdown Comparison
The maximum INNV drawdown since its inception was -89.92%, smaller than the maximum AMLX drawdown of -96.04%. Use the drawdown chart below to compare losses from any high point for INNV and AMLX.
Loading charts...
Drawdown Indicators
| INNV | AMLX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.92% | -96.04% | +6.12% |
Max Drawdown (1Y)Largest decline over 1 year | -33.21% | -30.61% | -2.60% |
Max Drawdown (3Y)Largest decline over 3 years | -65.42% | -92.82% | +27.40% |
Max Drawdown (5Y)Largest decline over 5 years | -84.76% | — | — |
Current DrawdownCurrent decline from peak | -56.37% | -50.38% | -5.99% |
Average DrawdownAverage peak-to-trough decline | -71.97% | -59.30% | -12.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.37% | 14.27% | +1.10% |
Volatility
INNV vs. AMLX - Volatility Comparison
The current volatility for InnovAge Holding Corp. (INNV) is 13.88%, while Amylyx Pharmaceuticals, Inc. (AMLX) has a volatility of 15.49%. This indicates that INNV experiences smaller price fluctuations and is considered to be less risky than AMLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INNV | AMLX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.88% | 15.49% | -1.61% |
Volatility (6M)Calculated over the trailing 6-month period | 51.14% | 39.64% | +11.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 82.81% | 61.22% | +21.59% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 74.83% | 90.71% | -15.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 72.87% | 90.71% | -17.84% |
Dividends
INNV vs. AMLX - Dividend Comparison
Neither INNV nor AMLX has paid dividends to shareholders.
Financials
INNV vs. AMLX - Financials Comparison
This section allows you to compare key financial metrics between InnovAge Holding Corp. and Amylyx Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
INNV and AMLX have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AMLX has higher volatility (15.49%) compared to INNV (13.88%). In terms of maximum drawdown, INNV dropped -89.92% vs AMLX's -96.04%.
INNV currently has the higher Sharpe Ratio (2.96 vs 2.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INNV and AMLX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer